Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia
暂无分享,去创建一个
L. Chang | T. Ernst | T. Ernst | O. Speck | E. Miller | M. Leonido-Yee | I. Walot | M. Witt | Linda Chang | I. Walot | O. Speck
[1] D. Karnofsky. The clinical evaluation of chemotherapeutic agents in cancer , 1949 .
[2] E. Richardson,et al. Corticodentatonigral degeneration with neuronal achromasia. , 1968, Archives of neurology.
[3] L. Bérubé,et al. [Clinical neuropsychology]. , 1982, Nursing Quebec.
[4] R. S. Williams,et al. Alzheimer's disease presenting as slowly progressive aphasia. , 1984, Rhode Island medical journal.
[5] B. Navia,et al. The AIDS dementia complex: I. Clinical features , 1986, Annals of neurology.
[6] P. Bottomley. Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.
[7] Karen L. Elkins,et al. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide , 1988, Nature.
[8] Bruce J. Brew,et al. The management of the neurological complications of HIV infection and AIDS. , 1988, AIDS.
[9] J. Phair,et al. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV‐1–infected individuals: Results from the multicenter AIDS cohort study , 1989, Annals of neurology.
[10] A. Lang,et al. Waht is it? Case 1, 1990: Progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb , 1990, Movement disorders : official journal of the Movement Disorder Society.
[11] C. Duyckaerts,et al. Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging , 1990, Neuroscience Letters.
[12] J. Becker,et al. Neuropsychological performance in HIV‐1‐infected homosexual men , 1990, Neurology.
[13] D. T. Vernier,et al. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.
[14] D. Giulian,et al. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1 , 1990, Science.
[15] W. Jagust,et al. Focal Alzheimer's disease , 1990, Neurology.
[16] E. Masliah,et al. Neocortical damage during HIV infection , 1991, Annals of neurology.
[17] Andrew J. Saykin,et al. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection , 1991, Neurology.
[18] R. V. Van Heertum,et al. Single-photon emission computed tomography in human immunodeficiency virus encephalopathy: a preliminary report. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] C D Marsden,et al. Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. , 1991, Brain : a journal of neurology.
[20] M. Pericak-Vance,et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. , 1991, American journal of human genetics.
[21] D. Gottlieb,et al. Mirror movements in the alien hand syndrome. Case report. , 1992, American journal of physical medicine & rehabilitation.
[22] C R Jack,et al. Asymmetric cortical degeneration syndromes. A proposed clinical classification. , 1992, Archives of neurology.
[23] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[24] J. Jankovic,et al. and J Jankovic The alien hand and related signs , 2022 .
[25] Roy E. Hoffman,et al. Improved Pulse Program for Long-Range Heteronuclear Correlation , 1993 .
[26] [Corticobasal degeneration: clinico-pathological studies on two cases]. , 1993, Rinsho shinkeigaku = Clinical neurology.
[27] G. D. Pearlson,et al. Reduced basal ganglia volume in HIV‐1‐associated dementia , 1993, Neurology.
[28] I. Wilkinson,et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. , 1993, Radiology.
[29] R. Lenkinski,et al. Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. , 1993, Radiology.
[30] C. Marsden,et al. Alien hand sign in association with Alzheimer's histopathology. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[31] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[32] T. Crawford,et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood‐brain barrier , 1993, Annals of neurology.
[33] B D Ross,et al. Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water , 1993 .
[34] D. Gadian,et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] B D Ross,et al. Absolute Quantitation of Water and Metabolites in the Human Brain. II. Metabolite Concentrations , 1993 .
[36] G. Fein,et al. Reduced brain N‐acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus‐seropositive individuals , 1993, Neurology.
[37] M. Albert,et al. Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer's disease. A community-based study. , 1993, Archives of neurology.
[38] A. Lang,et al. Case 1, 1994: Rapidly progressive aphasia, apraxia, dementia, myoclonus, and parkinsonism , 1994, Movement disorders : official journal of the Movement Disorder Society.
[39] C D Marsden,et al. Corticobasal degeneration: A clinical study of 36 cases , 1994 .
[40] H. Gendelman,et al. Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. , 1994, AIDS research and human retroviruses.
[41] A. Lang,et al. Parietal Pick's disease mimicking cortical‐basal ganglionic degeneration , 1994, Neurology.
[42] A. Hofman,et al. Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease , 1994, Nature Genetics.
[43] Linda Chang. In Vivo Magnetic Resonance Spectroscopy in HIV and HIV-Related Brain Diseases , 1995, Reviews in the neurosciences.
[44] C. Power,et al. HIV-1 Associated Dementia: Clinical Features and Pathogenesis , 1995, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[45] J. Haines,et al. Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives , 1995, Annals of neurology.
[46] M. Rossor,et al. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative. , 1995, American journal of medical genetics.
[47] Howard E. Gendelman,et al. Dementia Associated with the Acquired Immunodeficiency Syndrome , 1995 .
[48] D W Dickson,et al. Widespread cytoskeletal pathology characterizes corticobasal degeneration. , 1995, The American journal of pathology.
[49] C. Mathias,et al. Morphological overlap between corticobasal degeneration and Pick's disease: A clinicopathological report , 1995, Movement disorders : official journal of the Movement Disorder Society.
[50] B. Tycko,et al. Apolipoprotein E and alzheimer's disease: Ethnic variation in genotypic risks , 1995, Annals of neurology.
[51] A. Mackinnon,et al. Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sample , 1995, The Lancet.
[52] T. Ernst,et al. Elimination of artifacts in short echo time 1H MR spectroscopy of the frontal lobe , 1996, Magnetic resonance in medicine.
[53] D J Jenden,et al. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. , 1996, Life sciences.
[54] W. Tsai,et al. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. , 1996, American journal of human genetics.
[55] K. Jellinger,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.
[56] S C Strother,et al. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[57] J. Haines,et al. Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4. , 1996, American journal of human genetics.
[58] J. Hennig,et al. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. , 1996, Radiology.
[59] W. Brooks,et al. Apolipoprotein E genotyping in Alzheimer's disease in an Australian sample. , 1996, Australian and New Zealand journal of medicine.
[60] A. Saykin,et al. Proton spectroscopy in asymptomatic HIV-infected adults: initial results in a prospective cohort study. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[61] K. Davis,et al. Apolipoprotein E‐η4 allele and familial risk in Alzheimer's disease , 1996 .
[62] E M Wijsman,et al. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. , 1996, American journal of human genetics.
[63] C. Bergeron,et al. Unusual clinical presentations of cortical‐basal ganglionic degeneration , 1996, Annals of neurology.
[64] R. Schiffer,et al. Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study. , 1996, Archives of neurology.
[65] L. Wilkins. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder , 1996, Neurology.
[66] D. Dickson,et al. Neuropathologic Overlap of Progressive Supranuclear Palsy, Pick's Disease and Corticobasal Degeneration , 1996, Journal of neuropathology and experimental neurology.
[67] A. Guimarães,et al. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex , 1996, Neurology.
[68] J. Cohen. The Daunting Challenge of Keeping HIV Suppressed , 1997, Science.
[69] J. McArthur,et al. Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain , 1997, Annals of neurology.
[70] R. Lenkinski,et al. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[71] 新居康夫,et al. Does the central sulcus divide motor and sensory functions?Cortical mapping of human hand areas as revealed by electrical stimulation through subdural grid electrodes(硬膜下植え込み電極刺激法による手の大脳皮質運動知覚領野の局在に関する臨床的研究) , 1997 .
[72] H. Clifford Lane,et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies , 1997, Nature Medicine.
[73] A. Kertesz. Frontotemporal dementia, Pick disease, and corticobasal degeneration. One entity or 3? 1. , 1997, Archives of neurology.
[74] Manuel Battegay,et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study , 1997, BMJ.
[75] New Knockout Mice Point to Molecular Basis of Memory , 1997, Science.
[76] J. P. Brandel,et al. Accuracy of the Clinical Diagnosis of Corticobasal Degeneration , 1997, Neurology.
[77] Alan S. Perelson,et al. Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.
[78] N L Foster,et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference , 1997, Annals of neurology.
[79] G. Satten,et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.
[80] K. Marder,et al. The APOE- (cid:101) 4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics , 2001 .
[81] I Litvan,et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination , 1998, Journal of neurology, neurosurgery, and psychiatry.
[82] C Maurath,et al. Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. , 1998, Lancet.
[83] The APOE-epsilon4 allele and Alzheimer disease among African Americans, Hispanics, and whites. , 1998, JAMA.
[84] P. Lantos,et al. Familial dementia lacking specific pathological features presenting with clinical features of corticobasal degeneration , 1998, Journal of neurology, neurosurgery, and psychiatry.
[85] J. Leonard,et al. The duration of viral suppression during protease inhibitor therapy for HIV‐1 infection is predicted by plasma HIV‐1 RNA at the nadir , 1998, AIDS.
[86] K. Marder,et al. Validity of family history for the diagnosis of dementia among siblings of patients with late‐onset Alzheimer's disease , 1998, Genetic epidemiology.
[87] C. Marsden,et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. , 1998, Archives of neurology.
[88] Y. Agid,et al. Apolipoprotein E ϵ4 Allele and Familial Aggregation of Alzheimer Disease , 1998 .
[89] L. Chang,et al. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex , 1999, Neurology.
[90] L. Hakamies,et al. [Corticobasal degeneration]. , 2001, Duodecim; laaketieteellinen aikakauskirja.
[91] K. Marder,et al. Cortical basal ganglionic degeneration. , 2001, Science of aging knowledge environment : SAGE KE.
[92] Y. Kokubo,et al. [Apolipoprotein E]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.